Research Summary
Analyzed using Evidence Intelligence™

Bariatric surgery improves type 2 diabetes remission through gut microbiota changes

Last updated July 15, 2026

Key finding

Participants who underwent RYGB lost more weight compared to those who underwent SG.

This study investigated the effects of bariatric surgery on gut microbiota and type 2 diabetes remission, finding that Roux-en-Y gastric bypass (RYGB) led to greater weight loss and higher diabetes remission rates compared to sleeve gastrectomy (SG).

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Extended (5–20+ y)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study investigated the effects of bariatric surgery on gut microbiota and type 2 diabetes remission, finding that Roux-en-Y gastric bypass (RYGB) led to greater weight loss and higher diabetes remission rates compared to sleeve gastrectomy (SG).

Clinical relevance

These findings highlight the potential of Roux-en-Y gastric bypass as a more effective surgical intervention for patients with obesity and type 2 diabetes, suggesting that it may lead to better long-term health outcomes. Understanding the differential impacts of these surgical options can help clinicians make informed decisions when recommending treatments for patients struggling with obesity and diabetes.

Keep in mind

The study's sample size may limit the generalizability of the findings. Potential confounding variables were not fully controlled for in the analysis. The long-term effects beyond 12 months were not assessed.

Published in

Journal Reference

Publication details and source links for this paper.

Lisa MO, Heidi B, Rima MC, et al. Bariatric surgery alters gut microbiota and influences type 2 diabetes remission. Nature Metabolism. 2026;8(5):1212-1228. doi:10.1038/s42255-026-01525-9

Main Effects

RYGB resulted in a weight loss of -10.5 kg (p=0.001) compared to SG, which resulted in -8 kg (p=0.01).

Fasting plasma glucose decreased by -1.5 mmol/L (p=0.046) after RYGB, showing greater improvement than SG.

Diabetes remission was achieved in 74% of RYGB patients compared to 52% of SG patients (p=0.046).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Gastric bypass, Sleeve gastrectomy and Diabetes remission, Fasting Plasma Glucose (FPG), Insulin secretion levels after Roux-en-Y gastric bypass surgery, and 1 more.

Primary intervention

Gastric bypass

Primary outcomes

  • Diabetes remission
  • Fasting Plasma Glucose (FPG)
  • Insulin secretion levels after Roux-en-Y gastric bypass surgery

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

7
Evidence pairs
7
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

2

Related topics

7

Evidence pairs

244

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 7 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence relationship

Bariatric Procedures and Fasting Glucose

Related evidence

Evidence topic

Glycemic Control

Save evidence

Evidence topic

Bariatric Procedures

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Diabetes remission

Gastric bypass → Diabetes remission

Gastric bypass → Diabetes remission

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Fasting Plasma Glucose (FPG)

Gastric bypass → Fasting Plasma Glucose (FPG)

Gastric bypass → Fasting Plasma Glucose (FPG)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Insulin secretion levels after Roux-en-Y gastric bypass surgery

Gastric bypass → Insulin secretion levels after Roux-en-Y gastric bypass surgery

Gastric bypass → Insulin secretion levels after Roux-en-Y gastric bypass surgery

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Weight loss of 10% or more at 52 weeks

Gastric bypass → Weight loss of 10% or more at 52 weeks

Gastric bypass → Weight loss of 10% or more at 52 weeks

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Diabetes remission

Sleeve gastrectomy → Diabetes remission

Sleeve gastrectomy → Diabetes remission

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Fasting Plasma Glucose (FPG)

Sleeve gastrectomy → Fasting Plasma Glucose (FPG)

Sleeve gastrectomy → Fasting Plasma Glucose (FPG)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Weight loss of 10% or more at 52 weeks

Sleeve gastrectomy → Weight loss of 10% or more at 52 weeks

Sleeve gastrectomy → Weight loss of 10% or more at 52 weeks

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • RYGB led to a significant weight loss of -10.5 kg compared to -8 kg for SG.
  • Fasting plasma glucose improved more with RYGB, decreasing by -1.5 mmol/L.
  • Diabetes remission rates were higher with RYGB at 74% versus 52% for SG.
who this applies

Who this applies to

  • Adults with obesity and type 2 diabetes.
  • Patients considering bariatric surgery for weight management.
keep in mind

Keep in Mind

  • Results may not be applicable to all demographic groups due to sample characteristics.
  • The study focused on short-term outcomes; long-term effects remain uncertain.
  • Variability in individual responses to surgery may affect outcomes.
between the lines

Between the Lines

  • The study's sample size may limit the generalizability of the findings.
  • Potential confounding variables were not fully controlled for in the analysis.
  • The long-term effects beyond 12 months were not assessed.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Bariatric Procedures and Diabetes remission, Bariatric Procedures and Fasting Glucose.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Bariatric Procedures improve fasting glucose?

Moderate Evidence

Bariatric Procedures appears to improve Fasting Glucose.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Fasting Plasma Glucose (FPG)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.

Limitations

  • Only a small number of supporting studies are available.
  • Population details are unavailable.
2 supporting studiesUpdated: Jul 2026

Does Gastric bypass improve diabetes remission?

Emerging Evidence

Gastric bypass appears to improve Diabetes remission.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Diabetes remission

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Gastric bypass improve insulin secretion levels after roux-en-y gastric bypass surgery?

Emerging Evidence

Gastric bypass appears to improve Insulin secretion levels after Roux-en-Y gastric bypass surgery.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Insulin secretion levels after Roux-en-Y gastric bypass surgery

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Gastric bypass affect weight loss of 10% or more at 52 weeks?

Emerging Evidence

Gastric bypass appears to improve Weight loss of 10% or more at 52 weeks.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Weight loss of 10% or more at 52 weeks

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.